Abdominal Lymphoma Is Not A Clinical Diagnosis

This entry looks at one of those types of lymphoma sometimes referred to simply as abdominal lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

What is Abdominal Lymphoma?

Abdominal lymphoma is not a clinical diagnosis; the term does not represent a distinctly identified cancer. Instead, the term might best be considered an early descriptive term of a suspected lymphoma subtype that has as its primary site an area within the abdomen.

For instance, a person may be experiencing some pain or discomfort in their abdominal area, either from some enlarged abdominal lymph nodes or from a bulky mass that has developed on their spleen, liver, or along the gastrointestinal tract. If a PET/CT scan indicated cancerous activity there, the patient would likely have one of the swollen nodes biopsied. From there, the pathologist would make a more detailed determination of precisely what subtype of abdominal lymphoma is actually developing in the abdominal area. There are a few possibilities, such as:

  • Splenic marginal zone lymphoma (SMZL)
  • Nodal marginal zone B-cell lymphoma
  • Extranodal marginal B-cell lymphoma of MALT type
  • Diffuse large B-cell lymphoma

Abdominal Lymphoma and Nearby Lymph Nodes

The lymph node clusters most closely associated with abdominal lymphoma that develops in the abdomen are the mesenteric and the paraaortic lymph nodes, both clusters of which are located approximately around one's waistline, behind the intestines, and the iliac nodes, which are slightly lower than the first two sets and closer to the lower part of the abdomen.

Part of the recommended workup and clinical staging for any suspected abdominal lymphoma is a CT scan of the abdominal region and therefore help doctors make the right diagnosis so that the best possible treatment plans can be discussed. Because abdominal lymphoma is not a true subtype but rather could represent several different subtypes, it's impossible to know with any certainty anything regarding prognosis or survival rates. That information could only follow a proper diagnosis.

Photo: Pixabay

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap